Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.198,90
-1,82%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ T2 Biosystems Inc (TTOO) T2 Biosystems Inc (TTOO) Notizie

TTOO

T2 Biosystems (TTOO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTOO
DataOraFonteTitoloSimboloCompagnia
08/05/202401:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
07/05/202422:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
07/05/202422:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
07/05/202415:00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
06/05/202423:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
06/05/202423:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
06/05/202422:34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
24/04/202415:00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
11/04/202422:05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
28/03/202414:00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202412:30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
19/03/202414:00GlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
18/03/202414:00GlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
12/03/202414:00GlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
04/03/202422:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:49Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:06GlobeNewswire Inc.T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:04GlobeNewswire Inc.T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:02GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and AsiaNASDAQ:TTOOT2 Biosystems Inc
14/02/202402:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TTOOT2 Biosystems Inc
12/02/202415:00GlobeNewswire Inc.T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria PanelNASDAQ:TTOOT2 Biosystems Inc
07/02/202422:05GlobeNewswire Inc.T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024NASDAQ:TTOOT2 Biosystems Inc
18/01/202415:00GlobeNewswire Inc.T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia PatientsNASDAQ:TTOOT2 Biosystems Inc
03/01/202415:00GlobeNewswire Inc.T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric TestingNASDAQ:TTOOT2 Biosystems Inc
28/11/202322:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTOOT2 Biosystems Inc
24/11/202322:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTOOT2 Biosystems Inc
03/11/202314:00GlobeNewswire Inc.T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:TTOOT2 Biosystems Inc
01/11/202314:00GlobeNewswire Inc.T2 Biosystems Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TTOOT2 Biosystems Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTOO

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
CPR
Davide Campari
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
FBK
Finecobank
BIT
TRN
Terna Trasmissione Elett...
BIT
IRE
Iren
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network